Related Experiment Video
Updated: Aug 15, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6
Mutsumi Kanamori1, Chikatoshi Kai, Yoshihide Hayashizaki
1Laboratory for Genome Exploration Research Group, RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
Insights
NF-kappaB activator 1 (Act1) interacts with TRAF6, a key protein in the IL-1/Toll signaling pathway. This interaction is crucial for Act1
Area of Science:
- Molecular Biology
- Immunology
- Cell Signaling
Background:
- NF-kappaB activator 1 (Act1), also known as CIKS, is a protein involved in NF-kappaB and AP-1 activation.
- Act1 associates with the IkappaB kinase complex, playing a role in inflammatory signaling pathways.
Purpose of the Study:
- To investigate the interaction between Act1 and the TRAF family of proteins.
- To elucidate the role of Act1 in IL-1/Toll-mediated signaling pathways.
Main Methods:
- Protein interaction studies to confirm the binding of Act1 to TRAF6.
- Analysis of Act1's functional domains involved in TRAF6 interaction.
- Functional assays using dominant-negative TRAF6 mutants and Act1 expression levels to assess NF-kappaB activation.
Main Results:
- Act1 specifically interacts with tumor necrosis factor receptor-associated factor 6 (TRAF6) among all TRAF family proteins.
- The N-terminal half of Act1 is essential for its binding to the TRAF domain of TRAF6.
- Act1-mediated NF-kappaB activation is dose-dependently inhibited by a dominant-negative TRAF6 mutant.
- High expression of Act1 inhibits IL-1-induced NF-kappaB activation.
Conclusions:
- Act1 is a specific binding partner of TRAF6.
- Act1 plays a significant role in IL-1/Toll-mediated signaling pathways through its interaction with TRAF6.
Abstract:
NF-kappaB activator 1 (Act1), also called CIKS, is a recently identified protein with NF-kappaB and AP-1 activation activities through its association with the IkappaB kinase complex. We identified and confirmed that Act1 interacts with tumor necrosis factor receptor-associated factor 6 (TRAF6); notably, Act1 binds to TRAF6 only among TRAF family proteins. The amino-terminal half of Act1 is required for its interaction with the TRAF domain. Act1-mediated NF-kappaB activation was inhibited by a dominant-negative mutant of TRAF6 in a dose-dependent manner, and IL-1-induced NF-kappaB activation was inhibited by a high level of Act1 expression. Our results suggest that Act1 is involved in IL-1/Toll-mediated signaling through TRAF6.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades
TGF - β Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Affects Focal Adhesions
Some...

